Fiona Phillips shares early Alzheimer's symptoms that she dismissed as menopause
Fiona Phillips admits she had no idea she was suffering from Alzheimer's before her diagnosis three years ago. The former Good Morning Britain star, 64, who shares two children with ex-This Morning boss, Martin Frizell, initially put her symptoms, including brain fog, anxiety and a lack of interest in her marriage down to menopause. However, three years ago she was tragically told that she had the neurodegenerative disease, which both her parents suffered with.
Opening up about her early symptoms, Fiona said she had frequent anxiety attacks, "which became almost hourly". She also suffered from brain fog, a lack of confidence when driving and confusion, over the "simplest thing like opening a bank account".
She writes in an extract of her book, Adapted from Remember When: My Life With Alzheimer's, which is published in the Mail:"For me it was the sense of brain fog and a sense of anxiety that I could rarely shake off.
"The simplest thing, like going to the bank to ask about my account, would send me into a total panic, and there were mood swings too, which meant even I was finding my behaviour unpredictable."
Meanwhile, Fiona's marriage was coming under increasing strain. Blaming Alzheimer's for "at least part of it", she said: "I'm sure the disease was at least partly responsible, but at the time neither of us could see it. I just became more and more disconnected from Martin and the boys.
"'You've totally zoned out of our family and our marriage,' he [Martin] would say to me."
Putting her symptoms down to menopause after a leading expert appeared on This Morning, Fiona was taken in for tests.
Martin said: "Dr Newson was lovely. She had a long chat with Fiona and took blood tests. She also put her on a course of hormone replacement therapy. If it was the menopause, then within a couple of months the brain fog and anxiety symptoms should start to ease.
But when Fiona's condition failed to improve after a few months of the HRT treatment, the doctor read through Fiona's notes again and then, says Martin, "said the words I'd been hoping for so long never to hear" - that it may be something more than the menopause.
After a series of tests, including simple subtraction and being asked to draw intersecting rectangles, Fiona had an MRI, which was inconclusive. But, after she had a lumbar puncture she was told she had early-onset Alzheimer's.
Revealing that she and Martin went to the pub for a much-needed drink after the devastating news, Fiona writes stoically: "That afternoon in the pub it had seemed extraordinary that we could continue to live life 'as normally as possible', but that's exactly what we did from that moment on."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
40 minutes ago
- BBC News
Bristol student left partly paralysed after seizure led to FND
A student says her "whole life changed overnight" after having a seizure while out with her friends, leading to her becoming paralysed from the waist Watts-Martin, 21, from Bristol, was at university in Plymouth in 2023 when she had a serious seizure and was soon after diagnosed with Functional Neurological Disorder (FND) .The condition affects the way the brain and nervous system work and is one that health officials still have a "limited understanding" of, even though research into it is Watts-Martin is now trying to raise awareness of the illness and funds for equipment to help her stand again "one day" by doing a marathon in her wheelchair. "It was a very big change and a lot to deal with - my life pretty much changed overnight," she said."There's limited understanding of the condition and there's often this phrase used to describe it that says, 'it's not a hardware problem it's more of a software problem'." Health officials describe FND as a variable disorder that could be considered rare, but the exact number of people with it is with the disorder can have many symptoms that can vary from person to person - things such as functional seizures, limb weakness, tics and cognitive problems with dissociative and sensory issues. Ms Watts-Martin said she was "heartbroken" after she was unable to continue with her course, but was supported by her family in Bristol."My family were amazing," she said."The health support that's available is slim to nothing. I ended up going private with Plymouth Neurophysio."She has since moved to Plymouth Marjon University where she has found "joy" in wheelchair basketball and connected with a "supportive" community of wheelchair Watts-Martin aims to raise £2,000 by doing a marathon in her wheelchair throughout funds will go towards a new standing chair that will hopefully help her to "walk again one day "."I'll do bits of it in Plymouth, Bristol and anywhere else I can," she challenge starts on 1 August and will continue until the end of the month.
Scottish Sun
7 hours ago
- Scottish Sun
‘Game-changing' Alzheimer's drug could STOP disease in its tracks – as the ‘most powerful weapon' against condition yet
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A NEW "game-changing" drug could stop the progression of Alzheimer's disease, early trials suggest. Scientists say the treatment - called trontinemab - could be the most powerful weapon yet against dementia, as they look into giving the drug to people with no symptoms in the hopes of preventing disease. Sign up for Scottish Sun newsletter Sign up 1 Trontinemab is formulated to bypass the blood-brain barrier to target plaques clogging up brain cells Credit: Getty Phase two trial results for trontinemab were presented at he Alzheimer's Association International Conference in Toronto. Researchers said the drug seemed to clear plaques - the abnormal build-up of proteins around brain cells that cause damage and disrupt function - quicker than other drugs licensed to treat Alzheimer's. Trontinemab cleared out plaques and eliminated visible signs of the the disease within 28 weeks for nine out of 10 patients. Drug-maker Roche is now conducting another trial to see if plaque clearance also improves patients' memory. The 18-month study includes 1,600 people, the Telegraph reported. Separate research will examine whether the drug could be given to people without any signs of dementia, just as statins are used to ward off heart disease. Experts hope the drug could stop patients from developing dementia symptoms at all, if it is given early enough. They described the findings so far as 'very promising', suggesting that the drug was much more powerful than existing ones while leading to fewer side effects - as it was able to clear plaques better within seven months that other drugs can in 18 months. Roche's chief medical officer Levi Garraway said: 'Alzheimer's disease represents one of the greatest challenges in healthcare today and tackling it requires early detection and effective therapeutics. 'Trontinemab is designed to target a key driver of Alzheimer's disease biology more effectively in the brain. Common painkiller used for back pain ups risk of dementia by 29%, scientists warn "Combining new treatment avenues with advanced diagnostics may enable earlier and potentially more effective intervention. "With plans for phase three trials in both early symptomatic and pre-clinical Alzheimer's disease, we are advancing science with the goal of delaying - and ultimately preventing - progression of this devastating condition.' Prof Sir John Hardy, the chairman of molecular biology of neurological disease at University College London's Institute of Neurology told the Telegraph trontinemab could be 'game-changing'. The scientist, who was the first to identify the role of amyloid plaques in Alzeheimer's, said: 'This is absolutely great news. "It sucks the plaque out of the brain really quickly, much faster than we have seen with lecanemab or donanemab.' Both are Alzheimer's drugs approved for used in the UK, which target amyloid proteins in the brain to slow disease progression. However, neither treatment is offered on the NHS, as the National Institute for Health and Care Excellence (Nice) deemed them too expensive - in large part because patients need frequent scans to monitor for brain swelling and bleeds. Prof Hardy added: 'There is no doubt [trontinemab] could be game-changing. "We hope that if we can use these drugs to people early, we can halt the progression of disease, even before people have symptoms. "Now we need to see the size of the clinical effect. 'These results show it is much faster and safer than previous drugs, which means less monitoring. "That brings down the cost significantly, it means fewer MRI scans, so that would surely mean it would get Nice approval.' Early signs of dementia It's not unusual for your memory to lapse a bit as you get older. But dementia is different from 'just getting old' as it will cause noticeable - rather than gradual - changes to mental abilities and make managing everyday tasks and activities increasingly difficult. The symptoms of dementia may be small to start with, but get worse over time. Below are some examples of possible signs. Memory loss Memory loss is a key sign of dementia. This can include: Forgetting something you were only recently told. You may ask for the same information repeatedly – for example, 'Are the doors locked?' Putting objects in unusual places – for example, putting your house keys in the refrigerator. Being unable to learn new tasks, like how to use a new washing machine. Planning and decision making issues People with dementia can have difficulty with planning and decision making. This can include: Getting very confused when planning or thinking things through. Struggling to stay focused on a single task. Not making informed, careful decisions when dealing with money or looking at risks. Finding it hard to manage regular payments, budgets or monthly bills. Problems with language and understanding In people with dementia, this can manifest as: Having frequent problems finding the right word or regularly referring to objects as 'that thing'. Finding it hard to take part in conversations. Regularly being unable to follow what someone is saying even without distractions. Losing sense of time and place Dementia can cause problems with orientation, including: Losing track of the date, season or the passage of time. Getting lost in a place that is familiar or that should be easy to find your way around – for example, a supermarket. Regularly being unable to follow what someone is saying even without distractions. Problems with vision and perception This can mean having problems making sense of what you see. For example, having difficulty judging distances on stairs, or mistaking reflections or patterns for other objects. Mood and behavioural changes Finally, dementia can also make people act differently or shift their mood. This can mean: Becoming withdrawn and losing interest in work, friends or hobbies. Feeling unusually sad, anxious, frightened or low in confidence. Getting easily upset at home, at work, with friends or in places that usually feel comfortable or familiar. Source: Alzheimer's Society Trials for lecanemab and donanemab showed the drugs helped clear toxic clumps out of the brain and slow nerve damage caused by Alzheimer's by 27 per cent and 35 per cent respectively, over the course of 18 months. But the treatments did present a risk of brain swelling and brain bleeds, meaning patients needed intense monitoring. Trontinemab appears to be safer and cause fewer side effects, with less than five per cent of patients showing abnormal results on their brain scans. All of these cases were quickly resolved, researchers said. The drug - administered by infusion into the bloodstream - also doesn't need to be given a frequently. Upcoming trials will examine the impact of giving the drug to patients once a month for six months, then every three months. Trontinemab has been designed to efficiently bypass the blood-brain barrier, a protective layer of cells that stops harmful substances in the blood stream from attacking the brain and spinal cord. This barrier can make it hard for many drugs to reach the brain. Prof Jonathan Schott, the chief medical officer at Alzheimer's Research UK, told the Telegraph: 'We urgently need a range of treatments for Alzheimer's that are effective and safe for the people affected by this devastating disease. 'Evidence presented at the Alzheimer's Association conference in Toronto on trontinemab is very promising, showing that the drug can effectively and rapidly clear amyloid from the brain, seemingly with very few side effects. 'We now need to see whether these early stage results carry through to later stage clinical trials, which are planned to start later this year, including in the UK. "These trials will show whether the drug is not only safe, but impacts on memory, thinking and quality of life.' He said it was 'exciting' that the drug would now be tested in some people without symptoms under the phase three trials.
Daily Mirror
11 hours ago
- Daily Mirror
ITV's Dr Amir shares how 'weight stigma damages lives' in urgent warning to GPs
Dr Amir Khan, who regularly appears on ITV's This Morning, has shared a plea to doctors to take overweight patients more seriously. And he reckons many should take a leaf out of his book NHS GP Dr Amir Khan, who regularly appears on ITV's Lorraine and This Morning, has shared a passionate plea for doctors to take patients who are overweight more seriously, and not just put down all their ailments to how heavy they are. "Living in a larger body shouldn't mean you don't get equal healthcare access," he wrote as part of his Instagram caption. He shared there are five things his patients often say have stopped them receiving proper healthcare as they're overweight, and he made a passionate video, urging other NHS doctors not to get stuck in this rut of putting everything down to weight. Dr Amir said: "Living with obesity or excess weight is hard and can increase your risk of certain conditions, but not every illness is weight-related." He explained "weight stigma damages lives," giving examples of what his patients have said to him. 1. 'They blamed everything on my weight' Dr Amir said: "Patients come in with joint pain, breathlessness, irregular periods or low mood, and they walk out with one answer. 'You need to lose weight'. "No questions, no test, no curiosity, but health is multilayered, and treating weight like it's the root of every problem means serious conditions can get missed. "I've seen things like PCOS, autoimmune conditions, get delayed because no one looked past the BMI. It's not good medicine." 2. 'They wouldn't refer me until I lost weight' Dr Amir shared that "time and time again," patients are not referred for things like "fertility treatment, knee replacement, hernia repairs, and even mental health services" until they've lost weight. He said this isn't "just a barrier" but it's a "health delay with consequences". "For some, weight loss is extremely difficult due to genetics, trauma, medication side effects, or underlying health conditions. Delaying care means people live in pain, in shame, and in fear," he explained, saying it's "often the care that would really help them lose weight safely". 3. 'They didn't believe I eat healthily or exercise because of my weight' Dr Amir said: "We've been fed the myth that thin equals healthy, and fat equals lazy. But bodies are complicated. You can be metabolically healthy at a higher weight, and unhealthy at a lower weight. "Assumptions about a patient's lifestyle based on their appearance aren't just insulting, but they block meaningful support." 4. 'They ignored my pain' "People living in larger bodies are regularly told their pain, especially joint and pelvic pain, is simply the result of their weight, and sometimes, yes, weight does play a role. But that's not an excuse to stop looking," Dr Amir shared. He continued: "I've had patients with endometriosis, joint problems, fibroids, and inflammatory arthritis, all of whom have had their diagnosis delayed just because of their weight. "Being in a bigger body should never mean you're left to suffer." 5. 'I dreaded going to the doctor, so I stopped going' Dr Amir shared this one is "hard," saying when "people feel judged, shamed, or humiliated" when they visit their GP or the hospital, "they start avoiding care altogether". He explained that because of this, they can skip really important appointments, and they don't mention things "until it may be too late". The doctor said: "Weight stigma isn't just unkind, it's a barrier to healthcare. It widens inequalities, and it can cost lives. "So, I say to my patients, you are allowed to be heard before you lose weight. You deserve respect at every size." In the comments, someone wrote: "Thank you so much for recording this post, Amir. Your patients are so very lucky to have you as their GP. You are an amazing doctor and an amazing human being. You have a perfect soul full of kindness, empathy and compassion." Another wrote: "I resonate with number 5. Thanks for sharing; all doctors could take a leaf out of your book." "I think you could educate a lot of GPs," one woman added.
